Drug Type Small molecule drug |
Synonyms Oxaproxin, Oxaprozin (JP17/USP/INN), WY-21743 + [12] |
Target |
Action inhibitors |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (22 Aug 1985), |
Regulation- |
Molecular FormulaC18H15NO3 |
InChIKeyOFPXSFXSNFPTHF-UHFFFAOYSA-N |
CAS Registry21256-18-8 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Ankylosing Spondylitis | China | 01 Jan 1995 | |
| Cervicobrachial syndrome | China | 01 Jan 1995 | |
| Pain | China | 01 Jan 1995 | |
| Periarthritis | China | 01 Jan 1995 | |
| Post procedural inflammation | China | 01 Jan 1995 | |
| Juvenile Idiopathic Arthritis | United States | 29 Oct 1992 | |
| Bursitis | Japan | 22 Aug 1985 | |
| Gout | Japan | 22 Aug 1985 | |
| Low Back Pain | Japan | 22 Aug 1985 | |
| Osteoarthritis | Japan | 22 Aug 1985 | |
| Pain, Postoperative | Japan | 22 Aug 1985 | |
| Rheumatoid Arthritis | Japan | 22 Aug 1985 |





